We are live on
!
Find out more
Alyeska Investment Group Portfolio holdings
AUM
$35.4B
1-Year Est. Return
33.54%
This Fund
S&P 500
This Quarter
Est. Return
+8.78%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$9.66B
AUM Growth
+$1.09B
(+13%)
Cap. Flow
+$606M
Cap. Flow
% of AUM
6.27%
Top 10 Holdings %
Top 10 Hldgs %
17.35%
Holding
548
New
171
Increased
100
Reduced
111
Closed
146
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$302M |
| 2 |
Salesforce
CRM
|
+$147M |
| 3 |
GTLS
Chart Industries
GTLS
|
+$118M |
| 4 |
Atlassian
TEAM
|
+$110M |
| 5 |
Nike
NKE
|
+$99.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adobe
ADBE
|
+$253M |
| 2 |
SAP
SAP
|
+$151M |
| 3 |
Ciena
CIEN
|
+$115M |
| 4 |
Shopify
SHOP
|
+$105M |
| 5 |
Illumina
ILMN
|
+$103M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.86% |
| 2 | Healthcare | 15.66% |
| 3 | Industrials | 12.67% |
| 4 | Consumer Discretionary | 10.33% |
| 5 | Communication Services | 7.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CERE
301
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $2.77M | 0.03% |
87,782
| – | – |
|
302
Compass Therapeutics
CMPX
$400M
| $2.73M | 0.03% |
+545,170
| New | +$2.17M |
|
|
SOVO
303
DELISTED
Sovos Brands, Inc. Common Stock
SOVO
| $2.55M | 0.03% |
+177,553
| New | +$2.49M |
|
304
Syndax Pharmaceuticals
SNDX
$1.82B
| $2.54M | 0.03% |
+100,000
| New | +$2.33M |
|
|
NSA
305
DELISTED
National Storage Affiliates Trust
NSA
| $2.5M | 0.03% |
+69,166
| New | +$2.7M |
|
|
DFTX
306
Definium Therapeutics
DFTX
$5.99B
| $2.42M | 0.03% |
1,100,000
+100,000
| +10% | +$278K |
|
|
IAS
307
DELISTED
Integral Ad Science
IAS
| $2.42M | 0.03% |
+275,000
| New | +$2.33M |
|
308
Personalis
PSNL
$1.55B
| $2.3M | 0.02% |
1,161,672
+50,907
| +5% | +$128K |
|
309
Jacobs Solutions
J
$17.2B
| $2.27M | 0.02% |
22,860
-27,330
| -54% | -$2.68M |
|
310
Vaxcyte
PCVX
$8.67B
| $2.16M | 0.02% |
45,000
-7,100
| -14% | -$279K |
|
311
Paymentus
PAY
$4.91B
| $2.09M | 0.02% |
260,371
-1,120,102
| -81% | -$11M |
|
312
Tenaya Therapeutics
TNYA
$165M
| $2.08M | 0.02% |
+1,035,161
| New | +$2.53M |
|
|
SYBX
313
DELISTED
Synlogic
SYBX
| $2.05M | 0.02% |
180,138
-66,107
| -27% | -$807K |
|
314
Cummins
CMI
$87.4B
| $2.03M | 0.02% |
+8,361
| New | +$1.99M |
|
315
Boston Properties
BXP
$10.8B
| $2M | 0.02% |
+29,607
| New | +$2.1M |
|
|
NEX
316
DELISTED
NexTier Oilfield Solutions Inc.
NEX
| $2M | 0.02% |
215,921
-699,995
| -76% | -$6.85M |
|
317
Toast
TOST
$20.6B
| $1.98M | 0.02% |
110,000
-498,210
| -82% | -$9.36M |
|
|
MDVL
318
DELISTED
MedAvail Holdings, Inc. Common Stock
MDVL
| $1.97M | 0.02% |
131,520
-9,878
| -7% | -$284K |
|
319
Ormat Technologies
ORA
$6.87B
| $1.97M | 0.02% |
+22,769
| New | +$2.04M |
|
320
Amazon
AMZN
$3T
| $1.96M | 0.02% |
23,389
-232,654
| -91% | -$23M |
|
|
UBX
321
DELISTED
Unity Biotechnology
UBX
| $1.91M | 0.02% |
697,448
-588,552
| -46% | -$1.71M |
|
322
NewAmsterdam Pharma
NAMS
$3.34B
| $1.89M | 0.02% |
+200,000
| New | +$1.99M |
|
|
323
NewAmsterdam Pharma Warrant
NAMSW
$79.1M
| $1.89M | 0.02% |
+285,105
| New | +$235K |
|
|
LNKB
324
DELISTED
LINKBANCORP
LNKB
| $1.87M | 0.02% |
200,000
| – | – |
|
|
325
SAP
SAP
$241B
| $1.86M | 0.02% |
18,069
-1,509,784
| -99% | -$151M |
|
Similar funds
SAM
VIA
Alyeska Investment Group's Q4 2022 Portfolio in Review
As of Q4 2022, Alyeska Investment Group held 548 positions worth $9.66B, up 13% from $8.58B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Alyeska Investment Group deployed $606M of net new capital in Q4 2022, opening 171 new positions and adding to 100 existing holdings. Its largest new stake was Chart Industries: 737,397 shares worth $85M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 27% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was Adobe, an estimated $253M trimmed.
- Alyeska Investment Group's largest Q4 2022 buy was Chart Industries: 737,397 shares worth $85M.
- Alyeska Investment Group added most to Meta Platforms (Facebook) in Q4 2022, an estimated $302M increase.
- Alyeska Investment Group's biggest Q4 2022 reduction was Adobe, cutting an estimated $253M.
- Alyeska Investment Group fully exited Shopify in Q4 2022, selling an estimated $105M.
- Alyeska Investment Group's ten largest holdings make up 17% of its $9.66B portfolio in Q4 2022.
- Alyeska Investment Group opened 171 new positions and closed 146 in Q4 2022.
- Alyeska Investment Group's portfolio value rose 13% quarter-over-quarter to $9.66B.
Based on Alyeska Investment Group's 13F filing for Q4 2022, filed 14 Feb 2023.